Pateclizumab (MLTA3698A) is an immunomodulator.

It binds to lymphotoxin alpha.

Immune activation: Dostarlimab Other: Ibalizumab

This monoclonal antibody–related article is a stub.

You can help Wikipedia by expanding it.This antineoplastic or immunomodulatory drug article is a stub.